Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Mersana Therapeutics
3156
Mersana Therapeutics
Technology
Biotechnology
Health Care
Medical
Therapeutics
Rewriting the rules for immunoconjugate therapies.
Suggest edits
Founded
2005
Raised
$108M
Follow us
Also headquartered in Cambridge
MIT
Raspberry Pi
ARM
Xconomy
Biogen
Money Mover
HubSpot
Formlabs
Akamai
General Catalyst
Companies in the same industry
Promethera Biosciences
GigaGen
Codiak Biosciences
PeptiMimesis
Fulgent Diagnostics
DelMar Pharma
Milo Biotechnology
Annexon Biosciences
Theranica
Hookipa Pharma
Alexa global traffic share
Twitter followers
Overview
Funding
2
Add info
Latest funding
$75,000,000
IPO - 2017
$33,000,000
Venture capital (Series C) - 2016
Wellington Management
NEA
Rock Springs Capital
+3
Team Size
1–10
Employees
I work here
Location
Cambridge
,
United States
Headquarters
Explore Cambridge
Pulse 2.0
Mersana Therapeutics (MRSN): Should I Buy It Now?
Xconomy
FDA Puts Mersana Cancer Study on Partial Hold After Patient Death
Health
$75,000,000
IPO
PE HUB
VC-backed Mersana Therapeutics debuts IPO
Stock markets
Health
$33,000,000
Venture capital (Series C)
biospace
,
mersana
Booming Mersana Nabs Another 33 Million for a Total Take of 120 Million
Health
Funding
